3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
12
Multiple Myeloma
11
Lymphoma
10
Neoplasm Metastasis
9
Melanoma
7
Leukemia, Myeloid, Acute
7
Prostatic Neoplasms
6
Neuroblastoma
6
Carcinoma, Non-Small-Cell Lung
6
Wilms Tumor
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Fallopian Tube Neoplasms
5
Burkitt Lymphoma
5
Breast Neoplasms
5
Triple Negative Breast Neoplasms
4
Small Cell Lung Carcinoma
4
Rhabdoid Tumor
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Osteosarcoma
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Histiocytosis, Langerhans-Cell
4
Hepatoblastoma
4
Glioma
4
Ependymoma
4
Central Nervous System Neoplasms
4
Sarcoma, Kaposi
3
Sarcoma
3
Interventions
fludarabine phosphate
18
Peripheral Blood Stem Cell Transplantation
15
Whole-Body Irradiation
14
Mycophenolic Acid
14
Cyclophosphamide
14
Tacrolimus
10
Cyclosporine
10
Busulfan
10
Antilymphocyte Serum
10
Methotrexate
8
Melphalan
7
Etoposide
7
Sirolimus
5
Radiotherapy
5
Filgrastim
5
Cord Blood Stem Cell Transplantation
5
Granulocyte Colony-Stimulating Factor
4
Cytarabine
4
Cyclosporins
4
thymoglobulin
3
Methylprednisolone
3
Therapeutics
2
Rituximab
2
Ondansetron
2
Flow Cytometry
2
Dexamethasone
2
Carmustine
2
Carboplatin
2
Calcium Dobesilate
2
Aprepitant
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
×
Specimen Handling
×
Clear all
No trials found.